Answers are grounded in this paper and cite their sources.
It is the most common cancer in the world, and in the United States it is the fifth most common. It is common for liver cancer patients to be diagnosed at an advanced stage, which has a negative impact on their prognosis. Hepatocellular carcinomas (HCCs) account for more than 90% of all liver cancer cases, and chemotherapy and immunotherapy are the most effective treatments. Patients with liver cancer need new therapeutic choices. It's possible that natural chemicals and/or nanotechnology can improve patient outcomes while minimizing negative effects. Improved treatment options can lead to better outcomes. This study concludes by highlighting a few of the challenges people with liver cancer face, as well as some promising new treatments.
No takes yet. Share an insight, caveat, or question.
HUSSAIN et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: